✦ LIBER ✦

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

✍ Scribed by L. Rocchini; F. Pellucchi; B. Ibrahim; C. Maccagnano; M. Freschi; G. Zanni; L. Villa; G. Gandaglia; P. Capogrosso; N.M. Passoni; N. Fossati; R. Colombo

Book ID: 119622773
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 189 KB
Volume: 10
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(11)60422-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1770 NEOADJUVANT SHORT-TERM INTENSIVE IN

1770 NEOADJUVANT SHORT-TERM INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN COMPARED TO STANDARD SCHEDULE FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER. A RANDOMIZED PHASE II STUDY

✍ Rocchini, Lorenzo; Suardi, Nazareno; Federico, Pellucchi; Maccagnano, Carmen; Fa 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 206 KB

Neoadjuvant Short-term Intensive Intrave

Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study

✍ Renzo Colombo; Lorenzo Rocchini; Nazareno Suardi; Fabio Benigni; Giorgia Colciag 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 136 KB

POD-7.08: Intravesical Mitomycin C Versu

POD-7.08: Intravesical Mitomycin C Versus Bacillus Calmette-Guérin for Non-muscle Invasive Bladder Cancer: An Individual Patient Data Meta-analysis of Randomized Studies

✍ P. Malmström; R. Sylvester 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Re: Renzo Colombo, Lorenzo Rocchini, Naz

Re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study. Eur Urol 2012;62:797–802

✍ Manish Garg; Apul Goel; Jai Prakash 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

1051 Intracutaneous and intravesical imm

1051 Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin versus intravesical mitomycin-C for prevention of recurrences in patients with non-muscle-invasive bladder cancer: Results from a prospective randomized phase III trial

✍ Lammers, R.J.M.; Witjes, W.P.J.; Janzing-Pastors, M.H.C.; Caris, C.T.M.; Witjes, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 130 KB

651 IMMUNOTHERAPY OR CHEMOTHERAPY AS LOC

651 IMMUNOTHERAPY OR CHEMOTHERAPY AS LOCAL THERAPY OF URINARY BLADDER CANCER – WHICH IS THE MOST EFFECTIVE? REPORT ON A META-ANALYSIS OF THE LONG-TERM OUTCOME OF RANDOMIZED STUDIES COMPARING INTRAVESICAL MITOMYCIN C VERSUS BACILLUS CALMETTE-GUERIN FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ P.U. Malmström; R. Sylvester; E.D. Crawford; M. Friedrich; S. Krege; E. Rintala; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 563 KB